nodes	percent_of_prediction	percent_of_DWPC	metapath
Simvastatin—ABCB1—melanoma	0.188	1	CbGaD
Simvastatin—CYP3A4—Temozolomide—melanoma	0.0618	0.16	CbGbCtD
Simvastatin—ABCC2—Docetaxel—melanoma	0.0595	0.154	CbGbCtD
Simvastatin—CYP2D6—Vemurafenib—melanoma	0.0532	0.138	CbGbCtD
Simvastatin—CYP3A7—Docetaxel—melanoma	0.0397	0.103	CbGbCtD
Simvastatin—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0397	0.103	CbGbCtD
Simvastatin—ABCB1—Dactinomycin—melanoma	0.0375	0.0973	CbGbCtD
Simvastatin—CYP3A4—Vemurafenib—melanoma	0.0338	0.0877	CbGbCtD
Simvastatin—CYP3A5—Docetaxel—melanoma	0.0298	0.0772	CbGbCtD
Simvastatin—ABCB1—Docetaxel—melanoma	0.0194	0.0502	CbGbCtD
Simvastatin—CYP3A4—Docetaxel—melanoma	0.0116	0.0301	CbGbCtD
Simvastatin—Lovastatin—HDAC2—melanoma	0.00668	0.814	CrCbGaD
Simvastatin—Swelling—Carmustine—melanoma	0.00104	0.00572	CcSEcCtD
Simvastatin—Dysgeusia—Vemurafenib—melanoma	0.00102	0.00563	CcSEcCtD
Simvastatin—Blood alkaline phosphatase increased—Temozolomide—melanoma	0.00102	0.00561	CcSEcCtD
Simvastatin—Vascular purpura—Temozolomide—melanoma	0.000992	0.00545	CcSEcCtD
Simvastatin—Hepatic failure—Temozolomide—melanoma	0.000987	0.00542	CcSEcCtD
Simvastatin—Amnesia—Carmustine—melanoma	0.000977	0.00537	CcSEcCtD
Simvastatin—Amnesia—Temozolomide—melanoma	0.000944	0.00519	CcSEcCtD
Simvastatin—Purpura—Temozolomide—melanoma	0.000921	0.00506	CcSEcCtD
Simvastatin—Arthralgia—Vemurafenib—melanoma	0.00089	0.00489	CcSEcCtD
Simvastatin—Myalgia—Vemurafenib—melanoma	0.00089	0.00489	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.000883	0.00485	CcSEcCtD
Simvastatin—Drug interaction—Docetaxel—melanoma	0.000876	0.00481	CcSEcCtD
Simvastatin—Anaphylactic shock—Vemurafenib—melanoma	0.000853	0.00469	CcSEcCtD
Simvastatin—Infection—Vemurafenib—melanoma	0.000848	0.00466	CcSEcCtD
Simvastatin—Inflammation—Docetaxel—melanoma	0.000838	0.0046	CcSEcCtD
Simvastatin—Hepatocellular injury—Docetaxel—melanoma	0.000813	0.00447	CcSEcCtD
Simvastatin—Phosphatase alkaline increased—Docetaxel—melanoma	0.000813	0.00447	CcSEcCtD
Simvastatin—Muscular weakness—Carmustine—melanoma	0.00081	0.00445	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000799	0.00439	CcSEcCtD
Simvastatin—Muscular weakness—Temozolomide—melanoma	0.000783	0.0043	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000777	0.00427	CcSEcCtD
Simvastatin—Lovastatin—ABCB1—melanoma	0.000763	0.093	CrCbGaD
Simvastatin—Pravastatin—ABCB1—melanoma	0.000763	0.093	CrCbGaD
Simvastatin—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000749	0.00412	CcSEcCtD
Simvastatin—Decreased appetite—Vemurafenib—melanoma	0.000742	0.00408	CcSEcCtD
Simvastatin—Bronchitis—Temozolomide—melanoma	0.000737	0.00405	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Vemurafenib—melanoma	0.000737	0.00405	CcSEcCtD
Simvastatin—Fatigue—Vemurafenib—melanoma	0.000736	0.00404	CcSEcCtD
Simvastatin—Constipation—Vemurafenib—melanoma	0.00073	0.00401	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Temozolomide—melanoma	0.000713	0.00392	CcSEcCtD
Simvastatin—Erectile dysfunction—Temozolomide—melanoma	0.000706	0.00388	CcSEcCtD
Simvastatin—Depression—Carmustine—melanoma	0.000705	0.00388	CcSEcCtD
Simvastatin—Photosensitivity reaction—Temozolomide—melanoma	0.0007	0.00385	CcSEcCtD
Simvastatin—Neuropathy peripheral—Carmustine—melanoma	0.000694	0.00381	CcSEcCtD
Simvastatin—Depression—Temozolomide—melanoma	0.000682	0.00375	CcSEcCtD
Simvastatin—Hepatitis—Dactinomycin—melanoma	0.000679	0.00373	CcSEcCtD
Simvastatin—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.000678	0.00373	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000678	0.00372	CcSEcCtD
Simvastatin—Flushing—Bleomycin—melanoma	0.000675	0.00371	CcSEcCtD
Simvastatin—Body temperature increased—Vemurafenib—melanoma	0.000675	0.00371	CcSEcCtD
Simvastatin—Neuropathy peripheral—Temozolomide—melanoma	0.00067	0.00368	CcSEcCtD
Simvastatin—Swelling—Docetaxel—melanoma	0.000669	0.00368	CcSEcCtD
Simvastatin—Hepatic failure—Docetaxel—melanoma	0.000657	0.00361	CcSEcCtD
Simvastatin—Chills—Bleomycin—melanoma	0.000653	0.00359	CcSEcCtD
Simvastatin—Alopecia—Bleomycin—melanoma	0.000643	0.00353	CcSEcCtD
Simvastatin—Erythema multiforme—Dactinomycin—melanoma	0.000642	0.00353	CcSEcCtD
Simvastatin—Sinusitis—Temozolomide—melanoma	0.000641	0.00352	CcSEcCtD
Simvastatin—Erythema—Bleomycin—melanoma	0.000633	0.00348	CcSEcCtD
Simvastatin—Flushing—Dactinomycin—melanoma	0.00063	0.00346	CcSEcCtD
Simvastatin—Hypersensitivity—Vemurafenib—melanoma	0.000629	0.00345	CcSEcCtD
Simvastatin—Atrial fibrillation—Docetaxel—melanoma	0.000623	0.00342	CcSEcCtD
Simvastatin—Hepatitis—Temozolomide—melanoma	0.000614	0.00337	CcSEcCtD
Simvastatin—Asthenia—Vemurafenib—melanoma	0.000612	0.00336	CcSEcCtD
Simvastatin—Chills—Dactinomycin—melanoma	0.000609	0.00335	CcSEcCtD
Simvastatin—Pruritus—Vemurafenib—melanoma	0.000604	0.00332	CcSEcCtD
Simvastatin—Alopecia—Dactinomycin—melanoma	0.0006	0.0033	CcSEcCtD
Simvastatin—Erythema—Dactinomycin—melanoma	0.000591	0.00325	CcSEcCtD
Simvastatin—Flushing—Carmustine—melanoma	0.000589	0.00324	CcSEcCtD
Simvastatin—Ill-defined disorder—Bleomycin—melanoma	0.000588	0.00323	CcSEcCtD
Simvastatin—Anaemia—Bleomycin—melanoma	0.000585	0.00322	CcSEcCtD
Simvastatin—Diarrhoea—Vemurafenib—melanoma	0.000584	0.00321	CcSEcCtD
Simvastatin—Erythema multiforme—Temozolomide—melanoma	0.00058	0.00319	CcSEcCtD
Simvastatin—Malaise—Bleomycin—melanoma	0.000571	0.00314	CcSEcCtD
Simvastatin—Flushing—Temozolomide—melanoma	0.00057	0.00313	CcSEcCtD
Simvastatin—Leukopenia—Bleomycin—melanoma	0.000567	0.00312	CcSEcCtD
Simvastatin—Dizziness—Vemurafenib—melanoma	0.000564	0.0031	CcSEcCtD
Simvastatin—Alopecia—Carmustine—melanoma	0.000561	0.00308	CcSEcCtD
Simvastatin—Mental disorder—Carmustine—melanoma	0.000556	0.00306	CcSEcCtD
Simvastatin—Erythema—Carmustine—melanoma	0.000553	0.00304	CcSEcCtD
Simvastatin—Chills—Temozolomide—melanoma	0.000551	0.00303	CcSEcCtD
Simvastatin—Ill-defined disorder—Dactinomycin—melanoma	0.000548	0.00301	CcSEcCtD
Simvastatin—Anaemia—Dactinomycin—melanoma	0.000546	0.003	CcSEcCtD
Simvastatin—Vomiting—Vemurafenib—melanoma	0.000543	0.00298	CcSEcCtD
Simvastatin—Alopecia—Temozolomide—melanoma	0.000542	0.00298	CcSEcCtD
Simvastatin—Chest pain—Bleomycin—melanoma	0.000539	0.00296	CcSEcCtD
Simvastatin—Myalgia—Bleomycin—melanoma	0.000539	0.00296	CcSEcCtD
Simvastatin—Rash—Vemurafenib—melanoma	0.000538	0.00296	CcSEcCtD
Simvastatin—Mental disorder—Temozolomide—melanoma	0.000538	0.00295	CcSEcCtD
Simvastatin—Dermatitis—Vemurafenib—melanoma	0.000537	0.00295	CcSEcCtD
Simvastatin—Headache—Vemurafenib—melanoma	0.000535	0.00294	CcSEcCtD
Simvastatin—Erythema—Temozolomide—melanoma	0.000534	0.00294	CcSEcCtD
Simvastatin—Discomfort—Bleomycin—melanoma	0.000533	0.00293	CcSEcCtD
Simvastatin—Malaise—Dactinomycin—melanoma	0.000533	0.00293	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000531	0.00292	CcSEcCtD
Simvastatin—Cramp muscle—Docetaxel—melanoma	0.000531	0.00292	CcSEcCtD
Simvastatin—Leukopenia—Dactinomycin—melanoma	0.000529	0.00291	CcSEcCtD
Simvastatin—Dysgeusia—Temozolomide—melanoma	0.000523	0.00288	CcSEcCtD
Simvastatin—Confusional state—Bleomycin—melanoma	0.000521	0.00286	CcSEcCtD
Simvastatin—Vision blurred—Carmustine—melanoma	0.000521	0.00286	CcSEcCtD
Simvastatin—Tremor—Carmustine—melanoma	0.000518	0.00285	CcSEcCtD
Simvastatin—Anaphylactic shock—Bleomycin—melanoma	0.000517	0.00284	CcSEcCtD
Simvastatin—Oedema—Bleomycin—melanoma	0.000517	0.00284	CcSEcCtD
Simvastatin—Infection—Bleomycin—melanoma	0.000514	0.00282	CcSEcCtD
Simvastatin—Anaemia—Carmustine—melanoma	0.000511	0.00281	CcSEcCtD
Simvastatin—Nausea—Vemurafenib—melanoma	0.000507	0.00278	CcSEcCtD
Simvastatin—Thrombocytopenia—Bleomycin—melanoma	0.000506	0.00278	CcSEcCtD
Simvastatin—Vision blurred—Temozolomide—melanoma	0.000504	0.00277	CcSEcCtD
Simvastatin—Myalgia—Dactinomycin—melanoma	0.000503	0.00276	CcSEcCtD
Simvastatin—Tremor—Temozolomide—melanoma	0.000501	0.00275	CcSEcCtD
Simvastatin—Discomfort—Dactinomycin—melanoma	0.000497	0.00273	CcSEcCtD
Simvastatin—Ill-defined disorder—Temozolomide—melanoma	0.000496	0.00272	CcSEcCtD
Simvastatin—Leukopenia—Carmustine—melanoma	0.000495	0.00272	CcSEcCtD
Simvastatin—Anaemia—Temozolomide—melanoma	0.000494	0.00271	CcSEcCtD
Simvastatin—Anorexia—Bleomycin—melanoma	0.000493	0.00271	CcSEcCtD
Simvastatin—Angioedema—Temozolomide—melanoma	0.000488	0.00268	CcSEcCtD
Simvastatin—Oedema—Dactinomycin—melanoma	0.000482	0.00265	CcSEcCtD
Simvastatin—Malaise—Temozolomide—melanoma	0.000482	0.00265	CcSEcCtD
Simvastatin—Vertigo—Temozolomide—melanoma	0.00048	0.00264	CcSEcCtD
Simvastatin—Infection—Dactinomycin—melanoma	0.000479	0.00263	CcSEcCtD
Simvastatin—Leukopenia—Temozolomide—melanoma	0.000478	0.00263	CcSEcCtD
Simvastatin—Thrombocytopenia—Dactinomycin—melanoma	0.000472	0.00259	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000471	0.00259	CcSEcCtD
Simvastatin—Chest pain—Carmustine—melanoma	0.000471	0.00259	CcSEcCtD
Simvastatin—Myalgia—Carmustine—melanoma	0.000471	0.00259	CcSEcCtD
Simvastatin—Anxiety—Carmustine—melanoma	0.000469	0.00258	CcSEcCtD
Simvastatin—Paraesthesia—Bleomycin—melanoma	0.000464	0.00255	CcSEcCtD
Simvastatin—Dyspnoea—Bleomycin—melanoma	0.000461	0.00253	CcSEcCtD
Simvastatin—Anorexia—Dactinomycin—melanoma	0.00046	0.00253	CcSEcCtD
Simvastatin—Confusional state—Carmustine—melanoma	0.000455	0.0025	CcSEcCtD
Simvastatin—Arthralgia—Temozolomide—melanoma	0.000455	0.0025	CcSEcCtD
Simvastatin—Myalgia—Temozolomide—melanoma	0.000455	0.0025	CcSEcCtD
Simvastatin—Anxiety—Temozolomide—melanoma	0.000453	0.00249	CcSEcCtD
Simvastatin—Oedema—Carmustine—melanoma	0.000451	0.00248	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000451	0.00248	CcSEcCtD
Simvastatin—Discomfort—Temozolomide—melanoma	0.000449	0.00247	CcSEcCtD
Simvastatin—Decreased appetite—Bleomycin—melanoma	0.000449	0.00247	CcSEcCtD
Simvastatin—Infection—Carmustine—melanoma	0.000448	0.00246	CcSEcCtD
Simvastatin—Neuropathy peripheral—Docetaxel—melanoma	0.000446	0.00245	CcSEcCtD
Simvastatin—Jaundice—Docetaxel—melanoma	0.000443	0.00244	CcSEcCtD
Simvastatin—Pain—Bleomycin—melanoma	0.000442	0.00243	CcSEcCtD
Simvastatin—Thrombocytopenia—Carmustine—melanoma	0.000442	0.00243	CcSEcCtD
Simvastatin—Confusional state—Temozolomide—melanoma	0.00044	0.00242	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000439	0.00241	CcSEcCtD
Simvastatin—Oedema—Temozolomide—melanoma	0.000436	0.0024	CcSEcCtD
Simvastatin—Anaphylactic shock—Temozolomide—melanoma	0.000436	0.0024	CcSEcCtD
Simvastatin—Infection—Temozolomide—melanoma	0.000433	0.00238	CcSEcCtD
Simvastatin—Anorexia—Carmustine—melanoma	0.00043	0.00236	CcSEcCtD
Simvastatin—Thrombocytopenia—Temozolomide—melanoma	0.000427	0.00235	CcSEcCtD
Simvastatin—Feeling abnormal—Bleomycin—melanoma	0.000426	0.00234	CcSEcCtD
Simvastatin—Decreased appetite—Dactinomycin—melanoma	0.000419	0.0023	CcSEcCtD
Simvastatin—Fatigue—Dactinomycin—melanoma	0.000416	0.00228	CcSEcCtD
Simvastatin—Anorexia—Temozolomide—melanoma	0.000416	0.00228	CcSEcCtD
Simvastatin—Pain—Dactinomycin—melanoma	0.000412	0.00227	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Carmustine—melanoma	0.000411	0.00226	CcSEcCtD
Simvastatin—Urticaria—Bleomycin—melanoma	0.000411	0.00226	CcSEcCtD
Simvastatin—Body temperature increased—Bleomycin—melanoma	0.000409	0.00225	CcSEcCtD
Simvastatin—Hepatitis—Docetaxel—melanoma	0.000408	0.00224	CcSEcCtD
Simvastatin—Insomnia—Carmustine—melanoma	0.000408	0.00224	CcSEcCtD
Simvastatin—Paraesthesia—Carmustine—melanoma	0.000405	0.00223	CcSEcCtD
Simvastatin—Dyspnoea—Carmustine—melanoma	0.000402	0.00221	CcSEcCtD
Simvastatin—Feeling abnormal—Dactinomycin—melanoma	0.000397	0.00218	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000397	0.00218	CcSEcCtD
Simvastatin—Insomnia—Temozolomide—melanoma	0.000394	0.00217	CcSEcCtD
Simvastatin—Gastrointestinal pain—Dactinomycin—melanoma	0.000394	0.00217	CcSEcCtD
Simvastatin—Decreased appetite—Carmustine—melanoma	0.000392	0.00216	CcSEcCtD
Simvastatin—Paraesthesia—Temozolomide—melanoma	0.000392	0.00215	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Carmustine—melanoma	0.00039	0.00214	CcSEcCtD
Simvastatin—Dyspnoea—Temozolomide—melanoma	0.000389	0.00214	CcSEcCtD
Simvastatin—Erythema multiforme—Docetaxel—melanoma	0.000386	0.00212	CcSEcCtD
Simvastatin—Pain—Carmustine—melanoma	0.000386	0.00212	CcSEcCtD
Simvastatin—Constipation—Carmustine—melanoma	0.000386	0.00212	CcSEcCtD
Simvastatin—Dyspepsia—Temozolomide—melanoma	0.000384	0.00211	CcSEcCtD
Simvastatin—Body temperature increased—Dactinomycin—melanoma	0.000381	0.00209	CcSEcCtD
Simvastatin—Abdominal pain—Dactinomycin—melanoma	0.000381	0.00209	CcSEcCtD
Simvastatin—Hypersensitivity—Bleomycin—melanoma	0.000381	0.00209	CcSEcCtD
Simvastatin—Decreased appetite—Temozolomide—melanoma	0.000379	0.00208	CcSEcCtD
Simvastatin—Flushing—Docetaxel—melanoma	0.000379	0.00208	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Temozolomide—melanoma	0.000376	0.00207	CcSEcCtD
Simvastatin—Fatigue—Temozolomide—melanoma	0.000376	0.00207	CcSEcCtD
Simvastatin—Pain—Temozolomide—melanoma	0.000373	0.00205	CcSEcCtD
Simvastatin—Constipation—Temozolomide—melanoma	0.000373	0.00205	CcSEcCtD
Simvastatin—Feeling abnormal—Carmustine—melanoma	0.000372	0.00204	CcSEcCtD
Simvastatin—Asthenia—Bleomycin—melanoma	0.000371	0.00204	CcSEcCtD
Simvastatin—Gastrointestinal pain—Carmustine—melanoma	0.000369	0.00203	CcSEcCtD
Simvastatin—Chills—Docetaxel—melanoma	0.000366	0.00201	CcSEcCtD
Simvastatin—Pruritus—Bleomycin—melanoma	0.000366	0.00201	CcSEcCtD
Simvastatin—Alopecia—Docetaxel—melanoma	0.000361	0.00198	CcSEcCtD
Simvastatin—Feeling abnormal—Temozolomide—melanoma	0.000359	0.00197	CcSEcCtD
Simvastatin—Mental disorder—Docetaxel—melanoma	0.000358	0.00196	CcSEcCtD
Simvastatin—Body temperature increased—Carmustine—melanoma	0.000357	0.00196	CcSEcCtD
Simvastatin—Abdominal pain—Carmustine—melanoma	0.000357	0.00196	CcSEcCtD
Simvastatin—Gastrointestinal pain—Temozolomide—melanoma	0.000357	0.00196	CcSEcCtD
Simvastatin—Erythema—Docetaxel—melanoma	0.000355	0.00195	CcSEcCtD
Simvastatin—Hypersensitivity—Dactinomycin—melanoma	0.000355	0.00195	CcSEcCtD
Simvastatin—Dysgeusia—Docetaxel—melanoma	0.000348	0.00191	CcSEcCtD
Simvastatin—Urticaria—Temozolomide—melanoma	0.000346	0.0019	CcSEcCtD
Simvastatin—Asthenia—Dactinomycin—melanoma	0.000346	0.0019	CcSEcCtD
Simvastatin—Body temperature increased—Temozolomide—melanoma	0.000345	0.00189	CcSEcCtD
Simvastatin—Abdominal pain—Temozolomide—melanoma	0.000345	0.00189	CcSEcCtD
Simvastatin—Muscle spasms—Docetaxel—melanoma	0.000342	0.00188	CcSEcCtD
Simvastatin—Hypersensitivity—Carmustine—melanoma	0.000332	0.00183	CcSEcCtD
Simvastatin—Diarrhoea—Dactinomycin—melanoma	0.00033	0.00181	CcSEcCtD
Simvastatin—Vomiting—Bleomycin—melanoma	0.000329	0.00181	CcSEcCtD
Simvastatin—Anaemia—Docetaxel—melanoma	0.000328	0.0018	CcSEcCtD
Simvastatin—Rash—Bleomycin—melanoma	0.000326	0.00179	CcSEcCtD
Simvastatin—Dermatitis—Bleomycin—melanoma	0.000326	0.00179	CcSEcCtD
Simvastatin—Asthenia—Carmustine—melanoma	0.000324	0.00178	CcSEcCtD
Simvastatin—Hypersensitivity—Temozolomide—melanoma	0.000321	0.00177	CcSEcCtD
Simvastatin—Leukopenia—Docetaxel—melanoma	0.000318	0.00175	CcSEcCtD
Simvastatin—Asthenia—Temozolomide—melanoma	0.000313	0.00172	CcSEcCtD
Simvastatin—Diarrhoea—Carmustine—melanoma	0.000309	0.0017	CcSEcCtD
Simvastatin—Pruritus—Temozolomide—melanoma	0.000309	0.0017	CcSEcCtD
Simvastatin—Nausea—Bleomycin—melanoma	0.000307	0.00169	CcSEcCtD
Simvastatin—Vomiting—Dactinomycin—melanoma	0.000307	0.00168	CcSEcCtD
Simvastatin—Rash—Dactinomycin—melanoma	0.000304	0.00167	CcSEcCtD
Simvastatin—Chest pain—Docetaxel—melanoma	0.000303	0.00166	CcSEcCtD
Simvastatin—Myalgia—Docetaxel—melanoma	0.000303	0.00166	CcSEcCtD
Simvastatin—Arthralgia—Docetaxel—melanoma	0.000303	0.00166	CcSEcCtD
Simvastatin—Dizziness—Carmustine—melanoma	0.000298	0.00164	CcSEcCtD
Simvastatin—Diarrhoea—Temozolomide—melanoma	0.000298	0.00164	CcSEcCtD
Simvastatin—Confusional state—Docetaxel—melanoma	0.000292	0.00161	CcSEcCtD
Simvastatin—Oedema—Docetaxel—melanoma	0.00029	0.00159	CcSEcCtD
Simvastatin—Anaphylactic shock—Docetaxel—melanoma	0.00029	0.00159	CcSEcCtD
Simvastatin—Dizziness—Temozolomide—melanoma	0.000288	0.00158	CcSEcCtD
Simvastatin—Infection—Docetaxel—melanoma	0.000288	0.00158	CcSEcCtD
Simvastatin—Vomiting—Carmustine—melanoma	0.000287	0.00158	CcSEcCtD
Simvastatin—Nausea—Dactinomycin—melanoma	0.000286	0.00157	CcSEcCtD
Simvastatin—Rash—Carmustine—melanoma	0.000285	0.00156	CcSEcCtD
Simvastatin—Dermatitis—Carmustine—melanoma	0.000284	0.00156	CcSEcCtD
Simvastatin—Thrombocytopenia—Docetaxel—melanoma	0.000284	0.00156	CcSEcCtD
Simvastatin—Headache—Carmustine—melanoma	0.000283	0.00155	CcSEcCtD
Simvastatin—Vomiting—Temozolomide—melanoma	0.000277	0.00152	CcSEcCtD
Simvastatin—Anorexia—Docetaxel—melanoma	0.000276	0.00152	CcSEcCtD
Simvastatin—Rash—Temozolomide—melanoma	0.000275	0.00151	CcSEcCtD
Simvastatin—Dermatitis—Temozolomide—melanoma	0.000275	0.00151	CcSEcCtD
Simvastatin—Headache—Temozolomide—melanoma	0.000273	0.0015	CcSEcCtD
Simvastatin—Nausea—Carmustine—melanoma	0.000268	0.00147	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000264	0.00145	CcSEcCtD
Simvastatin—Insomnia—Docetaxel—melanoma	0.000262	0.00144	CcSEcCtD
Simvastatin—Paraesthesia—Docetaxel—melanoma	0.00026	0.00143	CcSEcCtD
Simvastatin—Nausea—Temozolomide—melanoma	0.000259	0.00142	CcSEcCtD
Simvastatin—Dyspnoea—Docetaxel—melanoma	0.000259	0.00142	CcSEcCtD
Simvastatin—Dyspepsia—Docetaxel—melanoma	0.000255	0.0014	CcSEcCtD
Simvastatin—Decreased appetite—Docetaxel—melanoma	0.000252	0.00139	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Docetaxel—melanoma	0.00025	0.00138	CcSEcCtD
Simvastatin—Fatigue—Docetaxel—melanoma	0.00025	0.00137	CcSEcCtD
Simvastatin—Pain—Docetaxel—melanoma	0.000248	0.00136	CcSEcCtD
Simvastatin—Constipation—Docetaxel—melanoma	0.000248	0.00136	CcSEcCtD
Simvastatin—Feeling abnormal—Docetaxel—melanoma	0.000239	0.00131	CcSEcCtD
Simvastatin—Gastrointestinal pain—Docetaxel—melanoma	0.000237	0.0013	CcSEcCtD
Simvastatin—Abdominal pain—Docetaxel—melanoma	0.000229	0.00126	CcSEcCtD
Simvastatin—Body temperature increased—Docetaxel—melanoma	0.000229	0.00126	CcSEcCtD
Simvastatin—Hypersensitivity—Docetaxel—melanoma	0.000214	0.00117	CcSEcCtD
Simvastatin—Asthenia—Docetaxel—melanoma	0.000208	0.00114	CcSEcCtD
Simvastatin—Pruritus—Docetaxel—melanoma	0.000205	0.00113	CcSEcCtD
Simvastatin—Diarrhoea—Docetaxel—melanoma	0.000198	0.00109	CcSEcCtD
Simvastatin—Dizziness—Docetaxel—melanoma	0.000192	0.00105	CcSEcCtD
Simvastatin—Vomiting—Docetaxel—melanoma	0.000184	0.00101	CcSEcCtD
Simvastatin—Rash—Docetaxel—melanoma	0.000183	0.001	CcSEcCtD
Simvastatin—Dermatitis—Docetaxel—melanoma	0.000183	0.001	CcSEcCtD
Simvastatin—Headache—Docetaxel—melanoma	0.000182	0.000998	CcSEcCtD
Simvastatin—Nausea—Docetaxel—melanoma	0.000172	0.000947	CcSEcCtD
Simvastatin—CYP3A7—Metabolism—ABCB1—melanoma	1.23e-05	5.21e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—ERCC2—melanoma	1.22e-05	5.19e-05	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.21e-05	5.15e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—FASN—melanoma	1.21e-05	5.14e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—GNA11—melanoma	1.21e-05	5.13e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PLA2G6—melanoma	1.2e-05	5.1e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.2e-05	5.1e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PLA2G6—melanoma	1.19e-05	5.06e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—SLC5A5—melanoma	1.19e-05	5.06e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PIP4K2A—melanoma	1.18e-05	5.02e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—SLC6A11—melanoma	1.18e-05	5.02e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—FASN—melanoma	1.18e-05	5.02e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.18e-05	5.02e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—VCAN—melanoma	1.17e-05	4.98e-05	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.17e-05	4.98e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PIK3CB—melanoma	1.17e-05	4.96e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—SLC5A5—melanoma	1.16e-05	4.94e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PTGS2—melanoma	1.16e-05	4.91e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—MTAP—melanoma	1.15e-05	4.89e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—GNAQ—melanoma	1.15e-05	4.88e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CD44—melanoma	1.15e-05	4.88e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—VCAN—melanoma	1.15e-05	4.86e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PIK3CD—melanoma	1.14e-05	4.83e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PRKCA—melanoma	1.13e-05	4.8e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PIK3CG—melanoma	1.13e-05	4.79e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CD44—melanoma	1.12e-05	4.77e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—GNAQ—melanoma	1.12e-05	4.77e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—ALB—melanoma	1.12e-05	4.77e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—ERCC2—melanoma	1.12e-05	4.76e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.11e-05	4.72e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CYP17A1—melanoma	1.11e-05	4.71e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CYP1B1—melanoma	1.1e-05	4.68e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.09e-05	4.64e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PPARG—melanoma	1.09e-05	4.62e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	1.08e-05	4.59e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—VCAN—melanoma	1.08e-05	4.58e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CYP1B1—melanoma	1.08e-05	4.58e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.07e-05	4.55e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—VCAN—melanoma	1.07e-05	4.54e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PIK3CG—melanoma	1.05e-05	4.47e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—GNA11—melanoma	1.05e-05	4.45e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—LUM—melanoma	1.03e-05	4.36e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PHGDH—melanoma	1.03e-05	4.36e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—FASN—melanoma	1.03e-05	4.35e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PPARG—melanoma	1.02e-05	4.31e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.01e-05	4.3e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.01e-05	4.3e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PTEN—melanoma	1.01e-05	4.28e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—SLC5A5—melanoma	1.01e-05	4.28e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—HPSE—melanoma	1.01e-05	4.27e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PIK3CB—melanoma	9.93e-06	4.21e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PIK3CD—melanoma	9.92e-06	4.21e-05	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	9.91e-06	4.21e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CYP17A1—melanoma	9.9e-06	4.2e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CUBN—melanoma	9.88e-06	4.19e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PTGS2—melanoma	9.84e-06	4.18e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—ALB—melanoma	9.79e-06	4.16e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.78e-06	4.15e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.77e-06	4.15e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CD44—melanoma	9.74e-06	4.13e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—GNAQ—melanoma	9.74e-06	4.13e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CYP17A1—melanoma	9.67e-06	4.1e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PIK3CG—melanoma	9.65e-06	4.09e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	9.64e-06	4.09e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—SDHD—melanoma	9.54e-06	4.05e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CSPG4—melanoma	9.54e-06	4.05e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—BSG—melanoma	9.54e-06	4.05e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.54e-06	4.05e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.45e-06	4.01e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—GNA11—melanoma	9.35e-06	3.97e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CYP1B1—melanoma	9.34e-06	3.96e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PPARG—melanoma	9.31e-06	3.95e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PIK3CD—melanoma	9.26e-06	3.93e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—GPAM—melanoma	9.24e-06	3.92e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—FASN—melanoma	9.15e-06	3.88e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—ALB—melanoma	9.14e-06	3.88e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—GNA11—melanoma	9.13e-06	3.87e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CYP17A1—melanoma	9.11e-06	3.87e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—ABCB1—melanoma	9.09e-06	3.86e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CYP17A1—melanoma	9.03e-06	3.83e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—SLC5A5—melanoma	9e-06	3.82e-05	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	8.95e-06	3.8e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—FASN—melanoma	8.93e-06	3.79e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.91e-06	3.78e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—ABCB1—melanoma	8.88e-06	3.77e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PIK3CG—melanoma	8.86e-06	3.76e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	8.79e-06	3.73e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—SLC5A5—melanoma	8.79e-06	3.73e-05	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PIK3CA—melanoma	8.73e-06	3.71e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CD44—melanoma	8.7e-06	3.69e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—GNAQ—melanoma	8.7e-06	3.69e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PIK3CB—melanoma	8.65e-06	3.67e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—GNA11—melanoma	8.6e-06	3.65e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PTEN—melanoma	8.58e-06	3.64e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PTGS2—melanoma	8.57e-06	3.64e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PPARG—melanoma	8.55e-06	3.63e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—GNA11—melanoma	8.53e-06	3.62e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.51e-06	3.61e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—GNAQ—melanoma	8.49e-06	3.6e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CD44—melanoma	8.49e-06	3.6e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PIK3CD—melanoma	8.48e-06	3.6e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.44e-06	3.58e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—FASN—melanoma	8.42e-06	3.57e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—ALB—melanoma	8.37e-06	3.55e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PRKCA—melanoma	8.36e-06	3.55e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—FASN—melanoma	8.35e-06	3.54e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CYP1B1—melanoma	8.34e-06	3.54e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—ERCC2—melanoma	8.29e-06	3.52e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—SLC5A5—melanoma	8.28e-06	3.51e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.24e-06	3.5e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—SLC5A5—melanoma	8.21e-06	3.48e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PRKCA—melanoma	8.17e-06	3.47e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CYP1B1—melanoma	8.14e-06	3.45e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—ERCC2—melanoma	8.11e-06	3.44e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PIK3CB—melanoma	8.07e-06	3.42e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—GNAQ—melanoma	8e-06	3.39e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CD44—melanoma	8e-06	3.39e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PTGS2—melanoma	7.99e-06	3.39e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—GNAQ—melanoma	7.93e-06	3.37e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CD44—melanoma	7.93e-06	3.37e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PLA2G6—melanoma	7.86e-06	3.34e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PIK3CD—melanoma	7.78e-06	3.3e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.76e-06	3.3e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.69e-06	3.26e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—ABCB1—melanoma	7.69e-06	3.26e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—ALB—melanoma	7.69e-06	3.26e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CYP1B1—melanoma	7.67e-06	3.25e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CYP1B1—melanoma	7.6e-06	3.23e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PTEN—melanoma	7.47e-06	3.17e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PIK3CB—melanoma	7.39e-06	3.14e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.36e-06	3.12e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PTGS2—melanoma	7.33e-06	3.11e-05	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—AKT1—melanoma	7.13e-06	3.03e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PIK3CA—melanoma	7.12e-06	3.02e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PRKCA—melanoma	7.08e-06	3e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—VCAN—melanoma	7.06e-06	3e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—ERCC2—melanoma	7.02e-06	2.98e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PTEN—melanoma	6.97e-06	2.96e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—ABCB1—melanoma	6.87e-06	2.91e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PIK3CB—melanoma	6.79e-06	2.88e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PTGS2—melanoma	6.72e-06	2.85e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.71e-06	2.85e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PIK3CG—melanoma	6.55e-06	2.78e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PIK3CG—melanoma	6.4e-06	2.72e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PTEN—melanoma	6.39e-06	2.71e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PPARG—melanoma	6.32e-06	2.68e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PRKCA—melanoma	6.32e-06	2.68e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—ABCB1—melanoma	6.31e-06	2.68e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—ERCC2—melanoma	6.27e-06	2.66e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—ABCB1—melanoma	6.26e-06	2.66e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PPARG—melanoma	6.18e-06	2.62e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PRKCA—melanoma	6.17e-06	2.62e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—ERCC2—melanoma	6.12e-06	2.6e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PIK3CA—melanoma	6.05e-06	2.57e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CYP17A1—melanoma	5.96e-06	2.53e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PTEN—melanoma	5.86e-06	2.49e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.82e-06	2.47e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—AKT1—melanoma	5.82e-06	2.47e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PRKCA—melanoma	5.81e-06	2.47e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—ERCC2—melanoma	5.76e-06	2.45e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PRKCA—melanoma	5.76e-06	2.44e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PIK3CD—melanoma	5.76e-06	2.44e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—ERCC2—melanoma	5.71e-06	2.42e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—ALB—melanoma	5.68e-06	2.41e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PIK3CD—melanoma	5.63e-06	2.39e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—GNA11—melanoma	5.62e-06	2.39e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—ALB—melanoma	5.56e-06	2.36e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PIK3CG—melanoma	5.54e-06	2.35e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—FASN—melanoma	5.5e-06	2.34e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—SLC5A5—melanoma	5.41e-06	2.3e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PPARG—melanoma	5.35e-06	2.27e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PIK3CA—melanoma	5.27e-06	2.24e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—GNAQ—melanoma	5.23e-06	2.22e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CD44—melanoma	5.23e-06	2.22e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.19e-06	2.2e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PIK3CB—melanoma	5.02e-06	2.13e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CYP1B1—melanoma	5.01e-06	2.13e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PTGS2—melanoma	4.97e-06	2.11e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PIK3CG—melanoma	4.95e-06	2.1e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—AKT1—melanoma	4.94e-06	2.1e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PIK3CA—melanoma	4.92e-06	2.09e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PIK3CB—melanoma	4.91e-06	2.08e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PIK3CD—melanoma	4.87e-06	2.07e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PTGS2—melanoma	4.86e-06	2.06e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PIK3CG—melanoma	4.83e-06	2.05e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—ALB—melanoma	4.81e-06	2.04e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PPARG—melanoma	4.78e-06	2.03e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.73e-06	2.01e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PPARG—melanoma	4.66e-06	1.98e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PIK3CG—melanoma	4.55e-06	1.93e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PIK3CG—melanoma	4.51e-06	1.92e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PIK3CA—melanoma	4.51e-06	1.91e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PPARG—melanoma	4.39e-06	1.86e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PPARG—melanoma	4.36e-06	1.85e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PIK3CD—melanoma	4.35e-06	1.85e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PTEN—melanoma	4.34e-06	1.84e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—AKT1—melanoma	4.31e-06	1.83e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—ALB—melanoma	4.29e-06	1.82e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PIK3CB—melanoma	4.25e-06	1.8e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PIK3CD—melanoma	4.25e-06	1.8e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PTEN—melanoma	4.24e-06	1.8e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PTGS2—melanoma	4.21e-06	1.79e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—ALB—melanoma	4.19e-06	1.78e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PIK3CA—melanoma	4.14e-06	1.76e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—ABCB1—melanoma	4.13e-06	1.75e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—AKT1—melanoma	4.02e-06	1.71e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PIK3CD—melanoma	4e-06	1.7e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PIK3CD—melanoma	3.97e-06	1.68e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—ALB—melanoma	3.95e-06	1.68e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—ALB—melanoma	3.92e-06	1.66e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PRKCA—melanoma	3.8e-06	1.61e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PIK3CB—melanoma	3.79e-06	1.61e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—ERCC2—melanoma	3.77e-06	1.6e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PTGS2—melanoma	3.76e-06	1.59e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PIK3CB—melanoma	3.7e-06	1.57e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—AKT1—melanoma	3.68e-06	1.56e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PTEN—melanoma	3.67e-06	1.56e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PTGS2—melanoma	3.67e-06	1.56e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PIK3CB—melanoma	3.49e-06	1.48e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PIK3CB—melanoma	3.46e-06	1.47e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PTGS2—melanoma	3.46e-06	1.47e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PTGS2—melanoma	3.43e-06	1.45e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—AKT1—melanoma	3.38e-06	1.43e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PTEN—melanoma	3.28e-06	1.39e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PTEN—melanoma	3.2e-06	1.36e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PIK3CA—melanoma	3.06e-06	1.3e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PTEN—melanoma	3.01e-06	1.28e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PIK3CA—melanoma	2.99e-06	1.27e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PTEN—melanoma	2.99e-06	1.27e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PIK3CG—melanoma	2.98e-06	1.26e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PPARG—melanoma	2.87e-06	1.22e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PIK3CD—melanoma	2.62e-06	1.11e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PIK3CA—melanoma	2.59e-06	1.1e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—ALB—melanoma	2.58e-06	1.1e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—AKT1—melanoma	2.5e-06	1.06e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—AKT1—melanoma	2.44e-06	1.04e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PIK3CA—melanoma	2.31e-06	9.81e-06	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PIK3CB—melanoma	2.28e-06	9.68e-06	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PTGS2—melanoma	2.26e-06	9.59e-06	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PIK3CA—melanoma	2.26e-06	9.58e-06	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PIK3CA—melanoma	2.13e-06	9.02e-06	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—AKT1—melanoma	2.12e-06	8.98e-06	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PIK3CA—melanoma	2.11e-06	8.95e-06	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PTEN—melanoma	1.97e-06	8.36e-06	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—AKT1—melanoma	1.89e-06	8.01e-06	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—AKT1—melanoma	1.84e-06	7.82e-06	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—AKT1—melanoma	1.74e-06	7.37e-06	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—AKT1—melanoma	1.72e-06	7.31e-06	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PIK3CA—melanoma	1.39e-06	5.9e-06	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—AKT1—melanoma	1.14e-06	4.82e-06	CbGpPWpGaD
